Post-mortem drug redistribution — A toxicological nightmare

https://doi.org/10.1016/0379-0738(90)90182-XGet rights and content

Abstract

Detailed human case data is presented to illustrate the dramatic extent of the phenomenon of post-mortem drug redistribution. The data suggests that there is a post-mortem diffusion of drugs along a concentration gradient, from sites of high concentration in solid organs, into the blood with resultant artefactual elevation of drug levels in blood. Highest drug levels were found in central vessels such as pulmonary artery and vein, and lowest levels were found in peripheral vessels such as subclavian and femoral veins. In individual cases, in multiple blood samples obtained from ligated vessels, concentrations of doxepin and desmethyldoxepin ranged from 3.6 to 12.5 mg/l and 1.2 to 7.5 mg/l, respectively; amobartital, secobarbital and pentobarbital from 4.3 to 25.8 mg/l, 3.9 to 25.3 mg/l and 5.1 to 31.5 mg/l respectively; clomipramine and desmethylclomipramine from 4.0 to 21.5 mg/l and 1.7 to 8.1 mg/l, respectively and flurazepam 0.15 to 0.99 mg/l; imipramine and desipramine from 4.1 to 18.1 mg/l and 1.0 to 3.6 mg/l, respectively. We conclude that this poorly studied phenomenon creates major difficulties in interpretation and undermines the reference value of data bases where the site of origin of post-mortem blood samples is unknown.

References (14)

  • A.S. Curry et al.

    The liver:blood ratio in cases of barbiturate poisoning

    Toxicol. Appl. Pharmacol.

    (1960)
  • D.J. Gee et al.

    Postmortem diagnosis of barbiturate poisoning

  • W.D. Holt et al.

    Postmortem assay of digoxin by radioimmunoassay

    J. Clin. Pathol.

    (1975)
  • T.E. Vorpahl et al.

    Correlation of antemortem and postmortem digoxin levels

    J. Forensic Sci.

    (1978)
  • R.W. Prouty et al.

    Postmortem redistribution of drugs

  • C. Peclet et al.

    Post-mortem release phenomenon: A study of blood levels in 121 cases of drug related deaths

  • J.M. Mayer et al.

    Postmortem changes in drug concentrations in the Blood

There are more references available in the full text version of this article.

Cited by (291)

  • Pharmacological data science perspective on fatal incidents of morphine treatment

    2023, Pharmacology and Therapeutics
    Citation Excerpt :

    In addition, RIA-derived concentrations should be disregarded because this historical method lacks specificity for morphine and therefore often results in falsely higher concentrations (Ferner, 2008; Yarema & Becker, 2005) and therefore have not been included in statistics and analyses of this article. Evidence of postmortem de-glucuronidation of M3G and M6G to morphine (Logan et al., 1997; Pounder & Jones, 1990; Prouty & Anderson, 1990; Skopp, 2004) or of postmortem increase or decrease of morphine concentrations in blood calls into question the reliability of above-mentioned morphine concentrations measured postmortem in a forensic medical context in which the causality of morphine dosing with and culpability for a patient's death is at issue. This has prompted several studies on changes in concentrations of morphine and its metabolites after death and on the interpretation of concentrations measured in exhumed material.

  • Stimulant use in suicides: A systematic review

    2022, Forensic Science International
View all citing articles on Scopus
View full text